Gefitinib/osimertinibDrug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1764卷 / 1期

关键词：

D O I：

10.1007/s40278-019-65570-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：146 / 146

相关论文

共 50 条

[41] Gefitinib/osimertinibDevelopment of drug resistance: case report
Reactions Weekly, 2020, 1812 (1) : 133 - 133
[42] Gefitinib/osimertinibHepatotoxicity and acquired resistance: case report
Reactions Weekly, 2022, 1923 (1) : 232 - 232
[43] Afatinib/gefitinib/nivolumabDevelopment of resistance: case report
Reactions Weekly, 2020, 1809 (1) : 14 - 14
[44] Afatinib/gefitinib/osimertinibAcquired resistance: case report
Reactions Weekly, 2020, 1810 (1) : 18 - 18
[45] Osimertinib/gefitinib/erlotinibDevelopment of resistance to osimertinib, gefitinib and erlotinib: case report
Reactions Weekly, 2017, 1654 (1) : 269 - 269
[46] OsimertinibDrug resistance secondary to C797S mutation: case report
Reactions Weekly, 2018, 1728 (1) : 276 - 276
[47] OsimertinibDrug-resistance: 8 case reports
Reactions Weekly, 2024, 2033 (1) : 227 - 227
[48] Afatinib/osimertinibDrug resistance: 5 case reports
Reactions Weekly, 2019, 1778 (1) : 18 - 18
[49] Erlotinib/osimertinibDrug resistance: 3 case reports
Reactions Weekly, 2021, 1874 (1) : 106 - 106
[50] Crizotinib/gefitinib/osimertinibEmergence of drug resistance: case report
Reactions Weekly, 2021, 1873 (1) : 86 - 86

← 1 2 3 4 5 →